Table 1 Overview of included studies conducted in Ethiopia (N = 2274), 2023
From: Dyslipidemia among HIV-infected patients in Ethiopia: a systematic review and meta-analysis
Authors (Year) | Region | Study design | Mean age (year) | Sample size | Dyslipidemia in at least one lipid profile N (%) | Dyslipidemia on ART N (%) | Dyslipidemia on treatment naïve N (%) | TC/HDL-c ratio > 5 (%) |
|---|---|---|---|---|---|---|---|---|
Tadewos et al. (2012) [31] | Southern | Cross-sectional | 37.2 ± 8.7 | 226 | 180 (79.6) | 93 (82.3) | 87 (76.9) | 43.4 |
Kemal et al. (2020) [32] | Addis Ababa | Cross-sectional | 44.2 ± 9.016 | 353 | 264 (74.8) | 264 (74.8) | NA | NA |
Aklog A. (2019) [33] | Addis Ababa | Cross-sectional | 33.9 ± 9.7 | 89 | 62 (69.7) | 62 (69.7) | NA | NA |
Wondiferaw et al. (2014) [34] | Addis Ababa | Cross-sectional | 35.31 ± 7.20 | 228 | 145 (63.6) | 84 (73.7) | 61 (53.5) | 32.5 |
Simeneh T. (2020) [35] | Addis Ababa | Cohort | 39.7 ± 10 | 63 | 49 (77.8) | 49 (77.8) | NA | 30.2 |
Tilahun et al. (2022) [36] | Amhara | Cross-sectional | 35.31 ± 7.20 | 228 | 145 (63.6) | 84 (73.7) | 61 (53.5) | NA |
Gebrie et al. (2020) [37] | Amhara | Cross-sectional | 38.6 ± 10.3 | 407 | 260 (63.9) | 260 (63.9) | NA | NA |
Fiseha et al. (2021) [38] | Amhara | Cross-sectional | 41.2 ± 14.4 | 392 | 235 (59.9) | 235 (59.9) | NA | NA |
Assefa et al. [23] | Addis Ababa | Cross-sectional | 43.5 ± 11.27 | 288 | 159 (55.2) | 159 (55.2) | NA | NA |